What do Parkinson's Disease, Alzheimer's Disease, cardiovascular disease, hypothyroidism, hypertension, and many other diseases have in common?  They all have age as their primary risk factor.   We believe our treatment will help patients suffering from these illnesses and many more and - as a by-product - provide regenerative effects for patients.  We have garnered the support of a Professor and Assistant Dean at UNLV medical school.  We have received Institutional Review Board approval to treat patients.   We are seeking $300k to complete the study (in additional to funds supplied by founder).  The treatment would be an off-label use of an FDA approved procedure.  Therefore we could quickly bring this treatment to the masses (and not have to wait a decade for approval).   Please review our presentation to see the science and our details.  https://www.dropbox.com/s/syuia911tnji79a/Alpha%20Sciences%20presentation%20Public%207-2020.pdf?dl=0